Initiatives and programs
We're working on a range of policy initiatives, programs and campaigns to help improve your health and the health of all Australians.
The Medical Research Future Fund (MRFF) is a $20 billion long-term investment supporting Australian health and medical research. The MRFF aims to transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability.
The Dementia, Ageing and Aged Care Mission is a research program that is investing $185 million from 2018–19 to 2028–29. It aims to support older Australians to maintain their health and quality of life as they age, live independently for longer, and access quality care when they need it.
This initiative provides $633 million over 10 years from 2019–20 and supports high-quality research that improves patient care, translates new discoveries into practice, and encourages consumers and researchers to work together on emerging priorities.
The Stem Cell Therapies Mission is a research funding program that will invest $150 million over 9 years to develop innovative, safe and effective treatments accessible to all Australians who need them.
The Traumatic Brain Injury Mission will invest $50 million over 10 years to improve patient recovery after brain injury. It will support projects that predict recovery outcomes, or identify the most effective care and treatments.
The Million Minds Mental Health Research Mission aims to support a million Australians with mental health issues access new approaches to prevention, diagnosis, treatment and recovery. The Medical Research Future Fund is providing $125 million over 10 years from 2018–19 for this mission.
Accelerated Research has been consolidated into the Emerging Priorities and Consumer-Driven Research initiative under the MRFF 10-year plan. This initiative supported researchers working to develop new treatments and cures for debilitating conditions, in areas of identified unmet need.
BioMedTech Horizons is now part of the Medical Research Commercialisation initiative under the MRFF 10-year plan.
This initiative invested $10 million in research to help promote good health practice, prevent disease and keep people out of hospital.
The Clinical Trials Activity initiative helps Australian researchers and patients test new treatments through national and international clinical trials.
The National Security Against Pandemic Risk initiative contributed to a global effort to develop vaccines against future pandemic diseases.
The Australian Government is investing $190.8 million over 10 years in the next generation of talented Australian researchers. This initiative supports health care professionals researching topics important to clinical care.
The Rapid Applied Research Translation initiative will provide $218 million over 10 years to accredited Translation Centres. These centres ‘translate’ research findings into clinical practice and deliver solutions to health service problems that affect patients.
Tackling Antimicrobial Resistance in Aged Care Facilities has been consolidated into the Global Health initiative under the MRFF 10-year plan. This initiative helped tackle the threat of microbes such as bacteria, viruses or parasites becoming resistant to standard medical treatments.
Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative has been consolidated into a part of the Clinical Trials Activity initiative under the MRFF 10-year plan.
Targeted Translation Research Accelerator has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year plan.
The Australian Government has established a program to support researchers to push the boundaries to develop new health and medical breakthroughs.
The Biomedical Translation Bridge (BTB) is now part of the Medical Research Commercialisation initiative under the MRFF 10-year plan.
The Researcher Exchange and Development within Industry (REDI) initiative is a $32 million investment over 4 years that brings universities and industry together. It will provide researchers with industry placements, mentoring and exchange programs.
The International Clinical Trial Collaboration (ICTC) initiative has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year plan. ICTC supported Australian researchers to conduct clinical trial research in collaboration with international researchers.
Keeping Australians out of Hospital has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year plan. This initiative supported research into preventive health measures for chronic health conditions, to keep people out of hospital.
Targeted Health System and Community Organisation Research has been consolidated into Preventive and Public Health Research under the MRFF 10-year plan. The activity provides a way to compare the effectiveness of health services and address areas of health care practice with low evidence.
Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year plan.
The Genomics Health Futures Mission will invest $500 million over 10 years in genomic research. It will improve testing and diagnosis for many diseases, help personalise treatment options to better target and improve health outcomes, and reduce unnecessary interventions and health costs.
The Australian Brain Cancer Mission is a $124 million fund that supports research into brain cancer treatments. It aims to double the survival rate of Australians living with brain cancer over the next 10 years.